Asymchem

Activities: Manufacturing Regulatory
Asymchem

Trending Articles

  1. Loftware and RiseNow partner to strengthen supply chain traceability and compliance in healthcare settings The alliance pairs Loftware's SAP-integrated product identification platform with RiseNow's procurement and supply chain advisory services, delivering end-to-end...
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Beyond drug discovery: the untapped value of AI in pharma operations The next phase of AI adoption in pharma could be less about discovering new medicines and more about tackling the operational barriers that prevent AI projects from scaling,...
  3. Andelyn Biosciences reaches commercial gene therapy manufacturing milestone with Fayuvi Andelyn Biosciences is manufacturing Ultragenyx’s FDA-approved Fayuvi gene therapy for commercial supply, marking the first FDA-approved therapy produced using its AAV...
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    The path toward autonomous biopharma manufacturing By connecting physical automation, robotics, AI and process knowledge into learning systems that accelerate development while preserving quality, safety and scientific rigour,...
  5. Bausch and Lomb hit with FDA Warning Letter for persistent microbial contamination The regulator cited persistent out-of-limit microbial recoveries in ISO 5 areas, deficiencies in aseptic processing and airflow controls and an ineffective quality system at...

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all

Related Content

Manufacturing
Inside the shift toward greener, faster, Smarter drug manufacturing

Inside the shift toward greener, faster, Smarter drug manufacturing

Dave Henderson, Ph.D, MBA, Head of R&D Labs at Asymchem explores the pharmaceutical manufacturing landscape and the challenges CDMOs must address to remain competitive in this shifting market
Manufacturing
Asymchem advances flow chemistry capabilities at UK Sandwich site with in-house equipment installation

Asymchem advances flow chemistry capabilities at UK Sandwich site with in-house equipment installation

Asymchem, a global leader in contract development and manufacturing (CDMO) solutions, has announced a significant expansion of its flow chemistry capabilities at its Sandwich, UK facility
Manufacturing
Asymchem officially launches new OEB5 facility: Enabling safe and efficient production of high-potency drugs

Asymchem officially launches new OEB5 facility: Enabling safe and efficient production of high-potency drugs

New OEB5 facility CPT <1 ng/m³, meeting the world's highest safety standards. It supports commercial HPAPI projects worldwide with >500 kg annual capacity. Full R&D, manufacturing and analytics integration with the Q3 2025 launch of the HPAPI R&D building
Manufacturing
Asymchem fully automates its therapeutic peptide manufacturing processes

Asymchem fully automates its therapeutic peptide manufacturing processes

The company has facilitated the scale-up of its peptide manufacturing capabilities, with its production capacity now standing at 10,000 L
Research & Development
Asymchem develops AI platform to optimise protein design in drug development

Asymchem develops AI platform to optimise protein design in drug development

Sequence Recommendation via Artificial Intelligence (STAR) addresses key challenges in protein design through intelligent algorithms and data-driven insights
Manufacturing
Asymchem extends its commitment to developing advanced manufacturing technologies

Asymchem extends its commitment to developing advanced manufacturing technologies

The company has invested significantly into bolstering its supply chain, while also creating advanced manufacturing technologies
Manufacturing
Asymchem inaugurates its UK small molecule development and API pilot plant manufacturing site

Asymchem inaugurates its UK small molecule development and API pilot plant manufacturing site

The site will focus on the manufacture of peptides and oligonucleotides, while also housing a number of R&D labs
Subscribe now